Skip to Main Content
Our Commitment to Diversity
Myla R. Reizen

Myla Reizen is a partner in the firm’s Miami office. She is a member of the global Health Care and FDA practice group.

Myla concentrates her practice in health law, representing health systems, hospitals, academic medical centers, clinical laboratories, home health agencies, skilled nursing facilities, hospices, physician groups, behavioral health providers and facilities, and other health care entities and providers.

Myla focuses her health care practice on government and internal investigations, health care regulatory matters, and health care compliance. 

She advises providers on government and qui tam matters ranging from medical necessity issues to physician arrangements and research compliance. Myla has significant experience working with the Department of Justice and Office of Inspector General on False Claims Act matters. 

Myla has extensive experience developing, implementing, and evaluating compliance programs and negotiating, analyzing, and implementing corporate integrity agreements. Along with compliance work, she also has handled complex regulatory and operational matters for providers involving a wide spectrum of laws, including the Stark Law, Anti-kickback Statute and the Eliminating Kickbacks in Recovery Act (EKRA). In addition to her in-depth expertise on federal issues, Myla has vast experience in complex state regulatory and enforcement matters. For instance, she has advised on reimbursement, licensure, fraud and abuse, and innovative and novel state programs. Myla provided a significant amount of guidance and resources to the nursing home and long term care communities during the pandemic.

Myla has substantial in-house experience serving in various in-house roles including as assistant general counsel for a national hospital company for a number of years. She is also an active member of the Florida Bar and has held leadership positions on the Florida Bar Health Law Executive Council. Myla devotes significant time giving back to the community. Myla currently serves on the Board of Directors for Dare To Care, a not for profit organization providing food, clothing, and basic needs to the South Florida Community. She previously served on the Board of Trustees for Florida Memorial University.

Myla is a frequent presenter in national and state venues on compliance and legal issues. She has been a contributor to a number of national and state publications.

  • “Hot Topics in Laboratory Settlement and Regulatory Issues,” Health Ethics Trust Webinar, March 2023
  • “What’s New in the Lab World-Recent Cases and Enforcement, ”Louisiana Bar-Health Law Section, 1 December 2022
  • “LTC Facilities in COVID Environment,” Louisiana Bar - Health Law Section, 4 December 2020
  • “Hot Topics in a COVID-19 Environment,” Florida Bar - Health Law Section, 30 October 2020
  • “Long Term Care Facility Infection Control,” Stafford Webinar, 20 September 2020
  • “Nursing Homes and Long Term Care Facilities - The New Regulatory and Overnight Landscape in the COVID-19 Environment,” ACI LTC Symposium, 16 August 2020
  • “Nursing Homes - The New Frontier in COVID-19 Environment,” Health Ethics Trust Webinar, 6 August 2020
  • “Nursing Homes: The New Frontier in the COVID-19 Environment," Healthcare Council of Western Pennsylvania Webinar, 28 May 2020
  • “Nursing Homes: The New Frontier in the COVID-19 Environment,” Health Ethics Trust Webinar, 18 May 2020
  • “Post Acute Care Recent Guidance and Lessons Learned,” Healthcare Council of Western Pennsylvania Webinar, 9 April 2020
  • “Stark and Physician Compensation: Hot Topics Do’s, Dont's, and Pitfalls,” Orlando, Florida, 24 January 2020
  • “Data Integrity, Certifications and Government Reporting: Where Do We Go From Here?,” New Orleans, Louisiana, 7 December 2019
  • “The Melding of Quality & Compliance,” Miami, Florida, 2 August 2019
  • “Recent Conflicts of Interest Events,” St. Augustine, Florida, 1 June 2019
Additional Thought Leadership Pages
  • Recent Trends in Clinical Laboratory Enforcement Action,” AHLA Bulletin, 6 July 2023
  • “An Update On The Eliminating Kickbacks in Recovery Act”, Law360, 4 March 2023
  • “How Nursing Home Operators Can Stay Atop Shifting Coronavirus Regulations,” Health Care Business Today, 28 July 2020
  • "COVID:19 case study: US long-term care facilities," Facility Perspectives, Vol. 14, No. 2.
  • “Multiple DOJ Settlements Relating to Electronic Health Records Systems- What Does This Mean for Health Care Entities Today?,” The RAP Sheet, a publication of the American Health Lawyers Association, 20 May 2019
Additional News & Event Pages
  • Quoted, “Tips on Assessing, Mitigating Compliance Risk Under EKRA,” Laboratory Economics, Volume 1 Number 3, May 2023
  • Quoted, “More Clarification, Better Definitions Needed in CMS Nursing Home Ownership Rule, Organizations Say,” McKnights, 19 April 2023
  • Quoted, “CMS ‘Demonizing’ Private Equity with Rule that Could Scare Away Skilled Nursing Investors,” McKnights, 17 April 2023
  • Quoted, “Genotox to Pay $5.9M to Settle Unnessesary Drug Testing Allegations,” Laboratory Economics, Volume 18, Number 4, April 2023
  • Quoted, "Provider Wins $2M Appeal at ALJ Over Modifier 25, Random Sample," Report on Medicare Compliance, Volume 30, Number 11, 22 March 2021
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel